Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) saw unusually large options trading on Wednesday. Stock traders bought 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical daily volume of 157 put options.
Evelo Biosciences Stock Down 80.0%
Shares of NASDAQ EVLO opened at $0.00 on Friday. The company has a market capitalization of $1,884.00, a PE ratio of 0.00 and a beta of 0.68. Evelo Biosciences has a twelve month low of $0.00 and a twelve month high of $0.00.
Evelo Biosciences Company Profile
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Featured Stories
- Five stocks we like better than Evelo Biosciences
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Strange Crystal Metal Outperforms Silicon Up to 100X
- 33,000% boom from weird new “AI Fuel?”
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
